Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Urs Fischer

Showing results (341-350 of 454) with videos related to

Pageof 46
Sort By:
European Stroke Journal|May 13, 2026
Gaps in the access to endovascular thrombectomy for acute ischaemic stroke: estimating neurointerventional training needs and modelling implementation impact based on current thrombectomy indicatorsAdnan Mujanovic, Michele Romoli, Giacomo Sferruzza, et al.
Stroke|May 22, 2025
Prior Reperfusion Strategy Does Not Modify Outcome in Early Versus Late Start of Anticoagulants in Patients With Ischemic Stroke: Prespecified Subanalysis of the Randomized Controlled ELAN TrialAnke Wouters, Jelle Demeestere, Jean-Benoît Rossel, et al.
Journal of Neurointerventional Surgery|July 10, 2019
Time of day and endovascular treatment decision in acute stroke with relative endovascular treatment indication: insights from UNMASK EVT international surveyJohanna Maria Ospel, Nima Kashani, Mayank Goyal, et al.
Frontiers in Neurology|October 2, 2025
Anticoagulant versus antiplatelet treatment for secondary stroke prevention in patients with active cancerMoritz C Kielkopf, Jayan Göcmen, Selina B Venzin, et al.
JAMA Network Open|January 28, 2025
Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical TrialAlexandros A Polymeris, Mattia Branca, P N Sylaja, et al.
European Heart Journal|March 12, 2021
Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL studyMarkus Arnold, Juliane Schweizer, Christos T Nakas, et al.
European Stroke Journal|December 8, 2022
Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): Protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trialUrs Fischer, Sven Trelle, Mattia Branca, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|May 27, 2023
Association of statin use and lipid levels with cerebral microbleeds and intracranial hemorrhage in patients with atrial fibrillation: A prospective cohort studyElisavet Moutzouri, Matthias Glutz, Nazanin Abolhassani, et al.
Journal of the American College of Cardiology|March 9, 2019
Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial FibrillationDavid Conen, Nicolas Rodondi, Andreas Müller, et al.
JAMA|July 2, 2021
Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 PandemicMayte Sánchez van Kammen, Mirjam R Heldner, Justine Brodard, et al.
Pageof 46

Showing results (341-350 of 454) with videos related to

Sort By:
Pageof 46
European Stroke Journal|May 13, 2026
Gaps in the access to endovascular thrombectomy for acute ischaemic stroke: estimating neurointerventional training needs and modelling implementation impact based on current thrombectomy indicatorsAdnan Mujanovic, Michele Romoli, Giacomo Sferruzza, et al.
Stroke|May 22, 2025
Prior Reperfusion Strategy Does Not Modify Outcome in Early Versus Late Start of Anticoagulants in Patients With Ischemic Stroke: Prespecified Subanalysis of the Randomized Controlled ELAN TrialAnke Wouters, Jelle Demeestere, Jean-Benoît Rossel, et al.
Journal of Neurointerventional Surgery|July 10, 2019
Time of day and endovascular treatment decision in acute stroke with relative endovascular treatment indication: insights from UNMASK EVT international surveyJohanna Maria Ospel, Nima Kashani, Mayank Goyal, et al.
Frontiers in Neurology|October 2, 2025
Anticoagulant versus antiplatelet treatment for secondary stroke prevention in patients with active cancerMoritz C Kielkopf, Jayan Göcmen, Selina B Venzin, et al.
JAMA Network Open|January 28, 2025
Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical TrialAlexandros A Polymeris, Mattia Branca, P N Sylaja, et al.
European Heart Journal|March 12, 2021
Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL studyMarkus Arnold, Juliane Schweizer, Christos T Nakas, et al.
European Stroke Journal|December 8, 2022
Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): Protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trialUrs Fischer, Sven Trelle, Mattia Branca, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|May 27, 2023
Association of statin use and lipid levels with cerebral microbleeds and intracranial hemorrhage in patients with atrial fibrillation: A prospective cohort studyElisavet Moutzouri, Matthias Glutz, Nazanin Abolhassani, et al.
Journal of the American College of Cardiology|March 9, 2019
Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial FibrillationDavid Conen, Nicolas Rodondi, Andreas Müller, et al.
JAMA|July 2, 2021
Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 PandemicMayte Sánchez van Kammen, Mirjam R Heldner, Justine Brodard, et al.
Pageof 46